Box-Behnken Design Based Optimization and Characterization of Gel Loaded with Hemidesmus Indicus-Enriched PtAuBNps for Anticancer Activity Against MCF-7 and B16F10 Cell Lines PtAuBNps Loaded Gel for Anticancer Activity Against Skin and Breast Cancer: Formulation and Optimization using Box Behnken Design

We effectively set the gel with incorporation of PtAuBNps using excellence by design technique. With the application of Box Behnken design to obtain 15 different batches. The design bounces optimized batch contingent on the viscosity and pH of the formulation. The special effects of autonomous aspects on pH and viscosity were critically measured by ANOVA and diagrammatically accessible by 3D surface graphs. The optimized batch exposed viscosity of 24.89 Pa.S, percent yield of 88.49% and pH of 6.52. The anticancer activity of gel was measured against breast cancer (MCF-7) cell lines and skin cancer (B16F10) cell lines. The outcomes point out the prospective of gel formulation against MCF-7 breast cancer cell lines. At the different doses (10 µg/ml to 100 µg/ml) of Formulation passed out for anticancer activity against MCF-7 cell line. IC50 value 38.10 µg/ml was detected that was decent to show cytotoxic action against standard drug 5 FU 32.31 µg/ml.
The gel system originates to be the novel method for the carriage of nanoparticles to the breast and skin cancer. Formulation of gel accelerates the site-specific delivery of nanoparticles and superior action towards the skin and breast cancer due to synergistic activity of bimetallic nanoparticles. The formulation desires to be auxiliary appraised for the physicochemical and pharmacological actions which will bring the novel delivery system for site specific action.